Paul Enever Ph.D

Paul Enever Ph.D General Information

Biography

Dr. Paul Enever serves as Partner at Evidity Health Capital. He serves as Board Member at Augmedics, Magnolia Medical Technologies, and Poseidon Medical. He serves as Chairman at Standard Molecular. He served as Board Member at Dune Medical Devices and Cardiva Medical. He has been working in the healthcare industry with a focus on med-tech for nearly 20 years. Before joining Evidity, he co-founded Evidity Health Capital with Alejandro Sanchez in 2014. He has been working in the healthcare industry with a focus on med tech for nearly 20 years. Before joining Evidity, he was a partner at McKinsey and Company. In his 12 years at McKinsey, he advised leading organizations across the biopharma, med tech, hospital, and healthcare services industries primarily in the U.S. and Europe as well as private equity firms specializing in healthcare. His work focused on growth strategy, sales and marketing, and licensing and acquisition. Previously, he worked within the R&D organization at Sandoz Pharmaceuticals and MIT's Biotechnology Process Engineering Center. He sits on the Boards of Directors of Augmedics, Magnolia Medical Technologies, Poseidon Medical, and Standard Molecular. He has a B.S. in chemical engineering from Rensselaer Polytechnic Institute and a Ph.D. in chemical engineering from the University of Minnesota where he studied wound healing and tissue engineering. For his work, he was the recipient of both a National Science Foundation Graduate Fellowship and the Whitaker Foundation Graduate Fellowship in Biomedical Engineering.